SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001347178-19-000003
Filing Date
2019-02-19
Accepted
2019-02-19 07:02:26
Documents
97
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K vnda1231201810k.htm 10-K 2096218
2 EXHIBIT 23.1 vnda12312018ex231.htm EX-23.1 2522
3 EXHIBIT 31.1 vnda12312018ex311.htm EX-31.1 12923
4 EXHIBIT 31.2 vnda12312018ex312.htm EX-31.2 12697
5 EXHIBIT 32.1 vnda12312018ex321.htm EX-32.1 8737
12 chart-e20050c3bd0c3e75ae7.jpg GRAPHIC 107830
  Complete submission text file 0001347178-19-000003.txt   9212087

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vnda-20181231.xml EX-101.INS 1833271
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vnda-20181231.xsd EX-101.SCH 70752
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vnda-20181231_cal.xml EX-101.CAL 129317
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vnda-20181231_def.xml EX-101.DEF 287678
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vnda-20181231_lab.xml EX-101.LAB 845513
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vnda-20181231_pre.xml EX-101.PRE 514624
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 19613376
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences